MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on March 20, 2007; DOI: 10.1124/mol.106.033241


0026-895X/07/7106-1666-1675$20.00
Mol Pharmacol 71:1666-1675, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.033241v1
71/6/1666    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Veale, E. L.
Right arrow Articles by Mathie, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Veale, E. L.
Right arrow Articles by Mathie, A.

G{alpha}q-Mediated Regulation of TASK3 Two-Pore Domain Potassium Channels: The Role of Protein Kinase C

Emma L. Veale, Louise E. Kennard, Gemma L. Sutton, Georgina MacKenzie, Cristina Sandu, and Alistair Mathie

Biophysics Section, Blackett Laboratory, Division of Cell & Molecular Biology, Imperial College London, London, United Kingdom (E.L.V., L.E.K., G.L.S., G.M., A.M.); and Department of Clinical Neurobiology, University of Heidelberg, Heidelberg, Germany (C.S.)

The TASK subfamily of two pore domain potassium channels (K2P) gives rise to leak potassium currents, which contribute to the resting membrane potential of many neurons and regulate their excitability. K2P channels are highly regulated by phosphorylation and by G protein-mediated pathways. In this study, we show that protein kinase C (PKC) inhibits recombinant TASK3 channels. Inhibition by PKC is blocked by the PKC inhibitors bisindolylmaleimide 1 hydrochloride (BIM) and 12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole (Gö6976). Gene-silencing experiments with a validated small interfering RNA sequence against PKC{alpha} ablates the effect of PKC. PKC acts directly on hTASK3 channels to phosphorylate an identified amino acid in the C terminus region (Thr341), thereby reducing channel current. PKC also inhibits mTASK3 channels despite their having a quite different C-terminal structure to hTASK3 channels. Activation of M3 muscarinic receptors inhibits both hTASK3 channels expressed in tsA-201 cells and standing outward potassium current (IKSO) in mouse cerebellar granule neurons through the activation of the G protein G{alpha}q, because both effects are abolished by the selective G{alpha}q antagonist YM-254890 (J Biol Chem 279:47438–47445, 2004). This inhibition is not directly transduced through activation of PKC because inhibition persists in mutated PKC-insensitive hTASK3 channels. Instead, inhibition seems to occur through a direct action of G{alpha}q on the channel. Nevertheless, preactivation of PKC blocks muscarinic inhibition of both TASK3 channels and IKSO. Our results suggest that activation of PKC (via phospholipase C) has a role in opposing inhibition after M3 receptor activation rather than transducing it and may act as a negative regulator of G protein modulation to prevent prolonged current inhibition.


Received December 6, 2006; accepted March 20, 2007

Address correspondence to: Dr. Alistair Mathie, Biophysics Section, Blackett Laboratory, Division of Cell and Molecular Biology, Imperial College London, London SW7 2AZ, UK. E-mail: a.mathie{at}imperial.ac.uk




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
G. Czirjak, D. Vuity, and P. Enyedi
Phosphorylation-dependent Binding of 14-3-3 Proteins Controls TRESK Regulation
J. Biol. Chem., June 6, 2008; 283(23): 15672 - 15680.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics